血管内介入治疗在大脑中动脉瘤破裂出血合并血肿中的效果分析

Abstract
Figure/Table
References (16)
Related Citation (15)

Download: PDF (0 KB) HTML (30 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the effect of intravascular interventional therapy in rupture and hemorrhage of middle cerebral artery aneurysm combined with hematoma. Methods Retrospective analysis of the clinical data of 33 patients with aneurysm admitted to the Fujian Provincial Hospital South Branch from June 2015 to December 2019. According to the different treatment methods, they were divided into the intervention group (18 cases) and the craniotomy group (15 cases). The interventional group received endovascular embolization, and the craniotomy group received craniotomy. The operation time, prognosis and postoperative complications of the two groups were compared. Results The operation time of the intervention group was shorter than that of the craniotomy group, the difference was statistically significant (P＜0.05). There was no significant difference in Glasgow outcome scale (GOS) score of the two groups after 12 months of follow-up (P>0.05). There was no significant difference in the incidence of hydrocephalus and cerebral infarction between the two groups (P＞0.05). The incidence of intracranial infection in the intervention group was lower than that in the craniotomy group, and the difference was statistically significant (P＜0.05). Conclusion There is no significant difference in the long-term prognosis between intravascular interventional therapy and craniotomy in the treatment of rupture and hemorrhage of middle cerebral artery aneurysm combined with hematoma. The former has shorter operation time and lower incidence of postoperative intracranial infection. Endovascular intervention is a safe and effective surgical method for such patients.

Key words： Intravascular interventional therapy Rupture and hemorrhage of middle cerebral artery aneurysm;Hematoma Therapeutic effect

Received: 25 June 2021

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors

Cite this article:

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2021/V28/I35/57

[1]	张伟平，屈洪党.蛛网膜下腔出血的诊断与治疗[J].中华全科医学，2019，17（3）：345-346.
[2]	秦超，刘竞丽.蛛网膜下腔出血的诊断与治疗[J].中华神经科杂志，2020，53（10）：814-818.
[3]	林令超，赛力克·对山拜.大脑中动脉动脉瘤破裂伴脑内血肿手术治疗研究进展[J].中国微侵袭神经外科杂志，2016，21（2）：94-96.
[4]	Xu H，Ding Wei.The risk factors of shunt-dependent hydrocephalus after subarachnoid space hemorrhage of intracranial aneurysms[J].Medicine，2019，98（27）：e15970.
[5]	Macdonald RL，Amidei C，Lin G，et al.Safety of Perioperative Subcutaneous Heparin for Prophylaxis of Venous Thromboembolism in Patients Undergoing Craniotomy[J].Neurosurgery，1999，45（2）：245-251.
[6]	范存刚，孙澎，张庆俊.2012 年AHA/ASA《动脉瘤性蛛网膜下腔出血的诊疗指南》解读[J].中华神经医学杂志，2013，12（6）：541-544.
[7]	曾国兴，李观海，吴登锋.颅内动脉瘤破裂并发脑内血肿急诊显微手术及血管内栓塞介入术治疗效果对比[J].卫生职业教育，2020，38（17）：151-152.
[8]	陈俊瑜，岑波，胡飞，等.大脑中动脉瘤破裂出血合并颅内血肿的显微外科治疗策略[J].临床神经外科杂志，2019，16（1）：71-73.
[9]	张绍林，黄金生，罗文伟，等.颅内动脉瘤破裂合并脑内血肿的早期手术治疗[J].中外医学研究，2019，17（29）：52-54.
[10]	韩彦军，张春阳.颅内破裂动脉瘤开颅夹闭术与介入栓塞术疗效的非随机对照临床试验[J].中西医结合心血管病电子杂志，2019，7（13）：30-31.
[11]	叶军，淦作松，魏林平.血管内介入栓塞术与开颅夹闭术治疗颅内动脉瘤的临床疗效对比分析[J].中国实用医药，2020，15（15）：29-31.
[12]	刘建民.颅内动脉瘤的血管内治疗——从血管重建到血流重构[J].中华神经外科杂志，2019，35（9）：865-867.
[13]	丰涛，赵瑞，许奕，等.颅内破裂微小动脉瘤血管内治疗的安全性和有效性[J].中国临床神经外科杂志，2020，25（5）：257-260.
[14]	邵田由，李兴，陈浩.内脏动脉瘤血管内治疗的进展[J].心血管外科杂志（电子版），2019，8（2）：209-211.
[15]	邓悦，吴世政.颅内动脉瘤血管内治疗现状[J].世界最新医学信息文摘（连续型电子期刊），2019，19（16）：119-120.
[16]	田向阳，张岭，孙来广，等.开颅手术与血管内栓塞对颅内后循环动脉瘤患者的疗效及颅脑损伤因子的影响[J].中国医药科学，2019，9（14）：14-18.